[Hippocampus-avoidance whole-brain radiation therapy with simultaneous integrated boost for multiple brain metastases in non-small cell lung cancer: a phase Ⅱ trial].

When non-small cell lung cancer spreads to the brain, patients often develop multiple tumors. A traditional treatment is radiating the entire brain, which can control the cancer but often causes severe memory loss. A recent early-stage clinical trial tested an advanced approach called hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost. In simple terms, doctors deliver a high dose of radiation directly to the tumors and a lower dose to the rest of the brain, all while carefully shielding the hippocampus, which is the brain's main memory center.

The results from this small study are highly encouraging. Among the brain tumors evaluated after treatment, nearly 67 percent completely disappeared, and over 23 percent shrank partially. On average, patients went more than 16 months before the treated tumors started to grow again, and over 11 months before any new tumor growth occurred in the brain.

Crucially, shielding the memory center seemed to work. The treatment was generally safe, with side effects occurring in about 26 percent of patients. Only one patient experienced severe memory impairment, and overall memory test scores showed only a very slight decline four months after treatment. However, researchers caution that this was a small, early-stage trial involving just 23 patients. Larger, randomized trials are necessary to confirm these early findings.